Small intestine bacterial overgrowth (SIBO) is one of the leading causes of Irritable Bowel Syndrome (IBS).
Patients with IBS symptoms are among the most frequent seen in clinical practice. Understanding how to successfully assess and treat SIBO, the cause of most IBS, can profoundly affect patient outcomes.
SIBO is caused by a translocation of bacteria into the small intestine (SI) as well as poor SI motility. Successful eradication of SIBO requires a comprehensive treatment approach. The last few years have seen an emergence of research and discoveries in this field.
Besides digestive symptoms, SIBO has been found to have far-reaching influences in an ever-increasing number of conditions such as fibromyalgia, gallstones, interstitial cystitis, acne rosacea, and malabsorption syndromes, to name just a few.
An exciting panel of speakers will be presenting at this day long summit in Melbourne and in Sydney.
Join leading SIBO experts discuss the latest evidence-based research, pharmacology, dietary interventions and other treatment options for managing small intestine bacterial overgrowth.
8:30am - 5pm Saturday 8 October, Melbourne - CQ Functions, 113 Queen St
8:30am - 5pm Monday, 10 October, Sydney- Rydges World Square, 389 Pitt St
Immerse yourself in a day of cutting edge research, updated treatment protocols, and new ideas on how to treat even your toughest SIBO patients.
- Update your knowledge about SIBO
- Learn from International SIBO experts
- Network with other SIBO professionals
- Mingle with SIBO relevant vendors